Biogen Inc.

Cambridge, United States

Biogen Inc. is a leading biotechnology company specializing in neuroscience and rare diseases, with a strong track record in developing therapies for multiple sclerosis, spinal muscular atrophy, and Alzheimer's disease. The firm pursues high-impact, high-risk research and strategic acquisitions to expand its portfolio. Biogen is recognized for its pioneering approach and long-term commitment to advancing innovative treatments.